Lead Product(s) : NVD-003
Therapeutic Area : Rare Diseases and Disorders
Study Phase : IND Enabling
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Novadip Biosciences receives IND approval from the FDA for regenerative bone product NVD-003
Details : NVD-003 is a novel autologous cell-based osteogenic (bone healing) product that has been generated from Novadip’s proprietary tissue regeneration platform. Made from adipose stem cells, NVD-003 has a 3-dimensional structure and works by promoting bone ...
Product Name : NVD-003
Product Type : Cell and Gene therapy
Upfront Cash : Inapplicable
April 03, 2021
Lead Product(s) : NVD-003
Therapeutic Area : Rare Diseases and Disorders
Highest Development Status : IND Enabling
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable